Pulmonary pathology include liquid biopsy (circulating tumor cells and cell free DNA) in patient plasma for lung cancer diagnostics and biomarker testing, immuno-oncology biomarker testing for immune checkpoint inhibitor therapy, cryobiopsy as a modality for diagnosing interstitial lung diseases without surgical biopsy and new multidisciplinary approaches to diagnosing interstitial lung diseases and new targeted therapies for these diseases.